Fujifilm Pharmaceuticals U.s.a., Inc.
Clinical trials sponsored by Fujifilm Pharmaceuticals U.s.a., Inc., explained in plain language.
-
New liposome chemo shows promise for tough cancers
Disease control OngoingThis early-phase study tests a new form of the chemotherapy drug topotecan, wrapped in a liposome (a tiny fat bubble), to see if it is safe and tolerable for people with advanced solid tumors that have not responded to standard treatments. The study includes cancers like ovarian,…
Phase: PHASE1 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy aims to stall advanced cancers
Disease control OngoingThis study tests an experimental drug (FF-10832) given alone or with pembrolizumab (an immunotherapy) in about 120 adults with advanced lung or bladder cancer that has not responded to standard treatments. The main goals are to check safety and see how long the cancer can be kept…
Phase: PHASE2 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated May 04, 2026 16:30 UTC